Correlation Between Silo Pharma and 36262GAD3
Specify exactly 2 symbols:
By analyzing existing cross correlation between Silo Pharma and GXO 265 15 JUL 31, you can compare the effects of market volatilities on Silo Pharma and 36262GAD3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of 36262GAD3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and 36262GAD3.
Diversification Opportunities for Silo Pharma and 36262GAD3
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Silo and 36262GAD3 is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and GXO 265 15 JUL 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GXO 265 15 and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with 36262GAD3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GXO 265 15 has no effect on the direction of Silo Pharma i.e., Silo Pharma and 36262GAD3 go up and down completely randomly.
Pair Corralation between Silo Pharma and 36262GAD3
Given the investment horizon of 90 days Silo Pharma is expected to under-perform the 36262GAD3. In addition to that, Silo Pharma is 2.17 times more volatile than GXO 265 15 JUL 31. It trades about -0.12 of its total potential returns per unit of risk. GXO 265 15 JUL 31 is currently generating about -0.24 per unit of volatility. If you would invest 8,534 in GXO 265 15 JUL 31 on September 14, 2024 and sell it today you would lose (715.00) from holding GXO 265 15 JUL 31 or give up 8.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 76.19% |
| Values | Daily Returns |
Silo Pharma vs. GXO 265 15 JUL 31
Performance |
| Timeline |
| Silo Pharma |
| GXO 265 15 |
Silo Pharma and 36262GAD3 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silo Pharma and 36262GAD3
The main advantage of trading using opposite Silo Pharma and 36262GAD3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, 36262GAD3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 36262GAD3 will offset losses from the drop in 36262GAD3's long position.| Silo Pharma vs. Protagenic Therapeutics | Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals |
| 36262GAD3 vs. JJill Inc | 36262GAD3 vs. Canada Goose Holdings | 36262GAD3 vs. Amkor Technology | 36262GAD3 vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |